IRIS - Res&Arch Institutional Research Information System - Research & Archive

CIPRIANI, Sabrina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.995
AS - Asia 2.005
EU - Europa 1.712
SA - Sud America 307
Continente sconosciuto - Info sul continente non disponibili 172
AF - Africa 46
OC - Oceania 4
Totale 7.241
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.905
SG - Singapore 962
IE - Irlanda 320
IT - Italia 307
CN - Cina 298
RU - Federazione Russa 247
HK - Hong Kong 244
BR - Brasile 237
VN - Vietnam 216
UA - Ucraina 157
FR - Francia 132
SE - Svezia 127
DE - Germania 94
FI - Finlandia 93
GB - Regno Unito 65
IN - India 54
TR - Turchia 50
CA - Canada 44
EE - Estonia 36
MX - Messico 29
BD - Bangladesh 28
KR - Corea 28
AR - Argentina 25
PL - Polonia 25
JP - Giappone 17
IQ - Iraq 16
CH - Svizzera 15
NL - Olanda 15
AT - Austria 14
ES - Italia 14
PK - Pakistan 14
RO - Romania 14
EC - Ecuador 13
UZ - Uzbekistan 13
ZA - Sudafrica 13
CO - Colombia 11
PH - Filippine 11
BE - Belgio 10
CZ - Repubblica Ceca 9
ID - Indonesia 8
SA - Arabia Saudita 8
LB - Libano 7
VE - Venezuela 7
EG - Egitto 6
KE - Kenya 6
CL - Cile 5
GR - Grecia 5
TW - Taiwan 5
LT - Lituania 4
CR - Costa Rica 3
DZ - Algeria 3
ET - Etiopia 3
HN - Honduras 3
JM - Giamaica 3
KG - Kirghizistan 3
MA - Marocco 3
MY - Malesia 3
NP - Nepal 3
PA - Panama 3
PE - Perù 3
PY - Paraguay 3
TN - Tunisia 3
AU - Australia 2
BN - Brunei Darussalam 2
HU - Ungheria 2
IL - Israele 2
JO - Giordania 2
NG - Nigeria 2
NO - Norvegia 2
PS - Palestinian Territory 2
SN - Senegal 2
SV - El Salvador 2
TH - Thailandia 2
UY - Uruguay 2
AL - Albania 1
AO - Angola 1
AZ - Azerbaigian 1
BF - Burkina Faso 1
CI - Costa d'Avorio 1
CV - Capo Verde 1
DO - Repubblica Dominicana 1
GT - Guatemala 1
IR - Iran 1
KH - Cambogia 1
KZ - Kazakistan 1
LU - Lussemburgo 1
LY - Libia 1
MD - Moldavia 1
MN - Mongolia 1
NR - Nauru 1
OM - Oman 1
PR - Porto Rico 1
PT - Portogallo 1
PW - Palau 1
QA - Qatar 1
RS - Serbia 1
SR - Suriname 1
Totale 7.069
Salva come PNG Salva come JPEG
Città #
Singapore 722
Chandler 396
San Jose 334
Dublin 319
Hong Kong 243
San Mateo 193
Ashburn 179
Dong Ket 134
Santa Clara 117
Perugia 109
Boardman 101
Beijing 95
Moscow 93
Ann Arbor 90
Altamura 88
Medford 78
Princeton 78
Jacksonville 70
Lawrence 69
Lauterbourg 67
Wilmington 65
Andover 63
Los Angeles 51
New York 35
Columbus 33
Izmir 32
São Paulo 32
The Dalles 30
Des Moines 27
Saint Petersburg 27
Seoul 27
Ho Chi Minh City 25
Munich 23
Dearborn 22
Helsinki 22
Orem 22
Dallas 18
Warsaw 18
Houston 17
Tokyo 16
Hanoi 15
Chicago 14
London 14
Timisoara 14
Chennai 13
Stockholm 13
Frankfurt am Main 12
Mexico City 12
Phoenix 12
San Paolo di Civitate 12
Norwalk 11
Redmond 11
Rio de Janeiro 11
Rome 11
Brussels 10
Falls Church 10
Johannesburg 10
Manchester 10
Montreal 10
Nuremberg 10
Toronto 10
Denver 9
Vienna 9
Woodbridge 9
Den Haag 8
Turku 8
Ankara 7
Baghdad 7
Boston 7
Buffalo 7
Council Bluffs 7
Guayaquil 7
Olomouc 7
Piscataway 7
Redwood City 7
Tashkent 7
Brooklyn 6
New Delhi 6
San Francisco 6
Seattle 6
Shanghai 6
Dhaka 5
Nairobi 5
Ottawa 5
Paris 5
Quito 5
Ribeirão Preto 5
Amsterdam 4
Atlanta 4
Campinas 4
Da Nang 4
Nanjing 4
Ninh Bình 4
Queens 4
Salvador 4
Addis Ababa 3
Bexley 3
Bishkek 3
Bogotá 3
Bắc Ninh 3
Totale 4.645
Salva come PNG Salva come JPEG
Nome #
Anti-HIV Protease Inhibitors Interact With NSAIDs and Exacerbate Small Intestine Enteropathy Induced by NSAIDs 151
The bile acid receptor GPBAR1 (TGR5) is expressed in human gastric cancers and promotes epithelial-mesenchymal transition in gastric cancer cell lines 149
The bile acid receptor GPBAR1 regulates the M1/M2 phenotype of intestinal macrophages and activation of gpbar1 rescues mice from murine colitis 148
Activation of the bile acid receptor GPBAR1 protects against gastrointestinal injury caused by non-steroidal anti-inflammatory drugs and aspirin in mice. 148
A Comprehensive Analysis of Small Heterodimer Partner (SHP) Target Genes in Hepatic Stellate Cells and the Discovery of a New Class of SHP Agonists That Reduces Liver Fibrosis 144
BAR502, a Dual FXR and GPBAR1 Agonist, Reverses Steatosis and Fibrosis in Rodent Model of NASH By Modulating Authophagic Genes 141
Microencapsulated G3C hybridoma cell graft delays the onset of spontaneous diabetes in NOD mice by an expansion of Gitr+ Treg cells 137
Bile acid-activated receptors in the treatment of dyslipidemia and related disorders. 136
Activation of the farnesoid-X receptor protects against gastrointestinal injury caused by non-steroidal anti-inflammatory drugs in mice. 136
Activation of FXR Improves Myocardial Fatty Acid Metabolism in a Rodent Model of Liver Steatosis 131
BAR 501, a Novel GPBAR1 Ligand, Reverses Intestinal and Liver Inflammatory Models Demonstrating That GPBAR1 Is an Essential Modulator of Innate Immunity in Entero-Hepatic Tissues 126
Efficacy of the CCR5 antagonist maraviroc in reducing early, ritonavir-induced atherogenesis and advanced plaque progression in mice. 124
Leflunomide protects against dyslipidemia development induced by ritonavir in mice 122
BAR501, A SELECTIVE GPBAR1 AGONIST, PROMOTES ADIPOSE TISSUE BROWNING AND AUTOPHAGY AND IMPROVES LIPID METABOLISM AND STEATO-HEPATITIS IN MICE FEED A HIGH FAT DIET 111
A Platelet's Guide to Synovitis 111
Dissociation of intestinal and hepatic activities of FXR and LXRα supports metabolic effects of terminal ileum interposition in rodents. 110
Glucocorticoid receptor mediates the gluconeogenic activity of the farnesoid X receptor in the fasting condition 107
Genetic and Pharmacological Dissection of the Role of Spleen Tyrosine Kinase (Syk) in Intestinal Inflammation and Immune Dysfunction in Inflammatory Bowel Diseases 106
Bile acid activated receptors are targets for regulation of integrity of gastrointestinal mucosa 105
BAR502, a dual FXR and GPBAR1 agonist, promotes browning of white adipose tissue and reverses liver steatosis and fibrosis 104
Counter-regulatory role of bile acid activated receptors in immunity andinflammation. 103
BAR130, A HYODEOXYCHOLIC ACID DERIVATIVE AS THE FIRST EXAMPLE OF DUAL LXR alpha/GPBAR1 AGONIST 103
Development of non-antibiotic macrolide that corrects inflammation-driven immune dysfunction in models of inflammatorybowel diseases and arthritis 100
Genetic Ablation and Pharmacological Blockade of CCR5 by the anti-HIV Small Molecule Inhibitor Maraviroc Inhibits Leukocyte Trafficking and Protects Against Mucosal Inflammation in Murine Models Colitis 98
Maraviroc Intensification Modulates Atherosclerotic Progression in HIV-Suppressed Patients at High Cardiovascular Risk. A Randomized, Crossover Pilot Study 98
A Novel Source of Intestinal Damage: The HIV Protease Inhibitor Ritonavir Worsens Damage Caused by COX Inhibitors 97
Probiotics modulate intestinal expression of nuclear receptor and provide counter-regulatory signals to inflammation-driven adipose tissue activation. 96
Discovery that theonellasterol a marine sponge sterol is a highly selective FXR antagonist that protects against liver injury in cholestasis. 96
DISCOVERY OF BAR704, A POTENT AND SELECTIVE FXR AGONIST, THAT PROTECTS AGAINST LIVER FIBROSIS 95
The Leukemic Isocitrate Dehydrogenase (IDH) 1/2 Mutations Impair Myeloid and Erythroid Cell Differentiation of Primary Human Hematopoietic Stem and Progenitor Cells (HSPCs) 94
The bile acid sensor farnesoid X receptor is a modulator of liver immunity in a rodent model of acute hepatitis. 94
The HIV Matrix Protein p17 subverts Nuclear Receptors Expression and induces a STAT1-Dependent Proinflammatory Phenotype in Monocytes 93
The bile acid receptor GPBAR-1 (TGR5) modulates integrity of intestinal barrier and immune response to experimental colitis. 92
Farnesoid X receptor suppresses constitutive androstane receptoractivity at the multidrug resistance protein-4 promoter. 91
Ritonavir-induced lipoatrophy and dyslipidaemia is reversed by the anti-inflammatory drug leflunomide in a PPAR-γ-dependent manner. 91
FXR mediates a chromatin looping in the GR promoter thus promoting the resolution of colitis in rodents. 90
Metabolic variability of a multispecies probiotic preparation impacts on the anti-inflammatory activity 90
The bile acid sensor FXR protects against dyslipidemia and aortic plaques development induced by the HIV protease inhibitor ritonavir in mice. 89
Cystathionine gamma-lyase, a H2S-generating enzyme, is a GPBAR1-regulated gene and contributes to vasodilation caused by secondary bile acids 89
Gpbar1 agonism promotes a Pgc-1α-dependent browning of white adipose tissue and energy expenditure and reverses diet-induced steatohepatitis in mice 89
Bile-acid-activated receptors: targeting TGR5 and farnesoid-X-receptor in lipid and glucose disorders. 89
Nanotraps with biomimetic surface as decoys for chemokines 87
The HIV Matrix Protein p17 promotes the Activation of human hepatic stellate cells through interactions with CXCR2 and Syndecan-2 86
CCR5 Antagonism by Maraviroc Reduces the Potential for Gastric Cancer Cell Dissemination. 84
Targetting farnesoid-X-receptor: from medicinal chemistry to disease treatment. 83
The nuclear receptor FXR regulates hepatic transport and metabolism of glutamine and glutamate 83
Exploitation of cholane scaffold for the discovery of potent and selective farnesoid X receptor (FXR) and G-protein coupled bile acid receptor 1 (GP-BAR1) ligands 83
Farnesoid X receptor agonist for the treatment of liver and metabolic disorders: focus on 6-ethyl-CDCA 82
Impaired Itching Perception in Murine Models of Cholestasis Is Supported by Dysregulation of GPBAR1 Signaling 81
VARIABILITY IN INDUSTRIAL PRODUCTION AFFECTS PROBIOTICS ACTIVITY: IDENTIFICATION OF BATCHES OF PROBIOTIC VSL#3 THAT INCREASES INTESTINAL PERMEABILITY AND WORSENS COLITIS IN RODENTS 79
Decoding the role of the nuclear receptor SHP in regulating hepatic stellate cells and liver fibrogenesis 77
Hydrogen sulphide induces micro opioid receptor-dependent analgesia in a rodent model of visceral pain. 76
In vivo administration of ritonavir worsens intestinal damage caused by cyclooxygease inhibitors. 76
Modulation of intestinal microbiota by the probiotic VSL#3 resets brain gene expression and ameliorates the age-related deficit in LTP. 76
GPBAR1 (TGR5) LIGATION PROTECTS AGAINST COLITIS DEVELOPMENT BY REGULATING LEUKOCYTE TRAFFINKING AND PROMOTING A IL-10 DEPENDENT SHIFT IN THE M1/M2 PHENOTYPE 74
SHP-dependent and -independent induction of peroxisomeproliferator-activated receptor-γ by the bile acid sensor farnesoid X receptorcounter-regulates the pro-inflammatory phenotype of liver myofibroblasts. 73
Instruction of Intestinal Microbiota by VSL#3 Reverses NASH and Accelerated Atherosclerosis Caused by Intestinal Inflammation in ApoE(-/-) Mice 73
Targeting Bile Acid Receptors: Discovery of a Potent and Selective Farnesoid X Receptor Agonist as a New Lead in the Pharmacological Approach to Liver Diseases 73
Pregnane-X-receptor mediates the anti-inflammatoryactivities of rifaximin on detoxification pathways in intestinal epithelialcells. 72
H2S Induces Analgesia Is Mediated In Vivo Activation of mu Opioid Receptor and PI3K/AKT Pathway Activation 72
Methotrexate improves endothelial function in early rheumatoid arthritis patients after 3 months of treatment 71
FXR Activation Reverses Insulin Resistance and Protects Against NASH Development 71
Solomonsterol A, a marine pregnane-X-receptor agonist, attenuates inflammation and immune dysfunction in a mouse model of arthritis. 70
The HIV matrix protein p17 induces hepatic lipid accumulation via modulation of nuclear receptor transcriptoma 70
Highly specific blockade of CCR5 inhibits leukocyte trafficking and reduces mucosal inflammation in murine colitis 68
Dietary habits and semen parameters: a systematic narrative review 67
Role of Maraviroc in a dyslipidemic murine model of atherosclerosis RTV-induced 66
Reversal of Endothelial Dysfunction by GPBAR1 Agonism in Portal Hypertension Involves a AKT/FOXOA1 Dependent Regulation of H2S Generation and Endothelin-1 66
Preterm Birth, Low Gestational Age, Low Birth Weight, Parity, and Other Determinants of Breech Presentation: Results from a Large Retrospective Population-Based Study 63
Essential Role of DNAX Adaptor Protein 12 (DAP12) and Spleen Tyrosine Kinase (Syk) in Inflammation-Driven Immune Dysfunction in Rodent Model of Colitis 62
The Bile Acid Receptor TGR5 Maintains Gastrointestinal Homeostasis and Its Activation Rescues From Gastrointestinal Injury Caused by ASA and NSAIDs 59
The bile acid sensor FXR is required for immune-regulatory activities of TLR-9 in intestinal inflammation 59
VSL#3 Resets Insulin Signaling and Protects against NASH and Atherosclerosis in a Model of Genetic Dyslipidemia and Intestinal Inflammation. 57
Probiotics VSL#3 protect against development of visceral pain in murine model of irritable bowel syndrome. 57
Modification on ursodeoxycholic acid (UDCA) scaffold. discovery of bile acid derivatives as selective agonists of cell-surface G-protein coupled bile acid receptor 1 (GP-BAR1). 57
Reciprocal Regulation of TLRS and Nuclear Receptors: IRF-7 Dependent Regulation of FXR Mediates Counter-Regulatory Effects of TLR-9 in Colitis 54
FXR Activation Corrects Immune-Dysfunction and Attenuates Inflammation in a Rodent Model of Hepatitis 51
Modification of Intestinal Microbiota by VSL#3 Protects Against Development of Pain in the Neonatal Maternal Separation Model. a Whole Genome Array Investigation 48
Mechanistic role of p38 MAPK in gastric cancer dissemination in a rodent model peritoneal metastasis. 47
Hyodeoxycholic acid derivatives as liver X receptor α and G-protein-coupled bile acid receptor agonists 47
EXTRAMEDULLARY INVOLVEMENT IN PATIENT-DERIVED XENOGRAFT MODELS OF ACUTE MYELOID LEUKEMIA (AML) WITH NUCLEOPHOSMIN (NPM-1) MUTATION 17
Totale 7.241
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.047
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.047
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022669 0 132 2 34 31 7 14 223 8 32 85 101
2022/20231.223 81 243 7 124 115 116 0 62 431 1 32 11
2023/2024394 31 52 25 3 2 2 97 13 10 20 84 55
2024/20251.161 16 88 47 42 166 66 28 69 231 71 196 141
2025/20262.511 152 145 145 270 325 216 464 145 334 213 70 32
2026/2027119 65 54 0 0 0 0 0 0 0 0 0 0
Totale 7.241